| Tumor-associated macrophages: from basic research to clinical application L Yang, Y Zhang Journal of hematology & oncology 10, 1-12, 2017 | 810 | 2017 |
| Tumor‐specific shared antigenic peptides recognized by human T cells P Van Der Bruggen, Y Zhang, P Chaux, V Stroobant, C Panichelli, ... Immunological reviews 188 (1), 51-64, 2002 | 587 | 2002 |
| Gasdermin E–mediated target cell pyroptosis by CAR T cells triggers cytokine release syndrome Y Liu, Y Fang, X Chen, Z Wang, X Liang, T Zhang, M Liu, N Zhou, J Lv, ... Science immunology 5 (43), eaax7969, 2020 | 365 | 2020 |
| T cell dysfunction and exhaustion in cancer Z Zhang, S Liu, B Zhang, L Qiao, Y Zhang, Y Zhang Frontiers in cell and developmental biology 8, 17, 2020 | 283 | 2020 |
| CD73 has distinct roles in nonhematopoietic and hematopoietic cells to promote tumor growth in mice L Wang, J Fan, LF Thompson, Y Zhang, T Shin, TJ Curiel, B Zhang The Journal of clinical investigation 121 (6), 2371-2382, 2011 | 282 | 2011 |
| CD39/CD73 upregulation on myeloid-derived suppressor cells via TGF-β-mTOR-HIF-1 signaling in patients with non-small cell lung cancer J Li, L Wang, X Chen, L Li, Y Li, Y Ping, L Huang, D Yue, Z Zhang, ... Oncoimmunology 6 (6), e1320011, 2017 | 271 | 2017 |
| Reactive oxygen species regulate T cell immune response in the tumor microenvironment X Chen, M Song, B Zhang, Y Zhang Oxidative Medicine and Cellular Longevity 2016, 2016 | 267 | 2016 |
| Messenger RNA-electroporated dendritic cells presenting MAGE-A3 simultaneously in HLA class I and class II molecules A Bonehill, C Heirman, S Tuyaerts, A Michiels, K Breckpot, F Brasseur, ... The Journal of Immunology 172 (11), 6649-6657, 2004 | 253 | 2004 |
| Metformin-induced reduction of CD39 and CD73 blocks myeloid-derived suppressor cell activity in patients with ovarian cancer L Li, L Wang, J Li, Z Fan, L Yang, Z Zhang, C Zhang, D Yue, G Qin, ... Cancer research 78 (7), 1779-1791, 2018 | 228 | 2018 |
| Phase 1/2 study of subcutaneous and intradermal immunization with a recombinant MAGE‐3 protein in patients with detectable metastatic melanoma WHJ Kruit, HH Van Ojik, VG Brichard, B Escudier, T Dorval, B Dréno, ... International journal of cancer 117 (4), 596-604, 2005 | 198 | 2005 |
| Selective depletion of regulatory T cell subsets by docetaxel treatment in patients with nonsmall cell lung cancer JY Li, XF Duan, LP Wang, YJ Xu, L Huang, TF Zhang, JY Liu, F Li, ... Journal of immunology research 2014, 2014 | 177 | 2014 |
| T-cell receptor-engineered T cells for cancer treatment: current status and future directions Y Ping, C Liu, Y Zhang Protein & cell 9 (3), 254-266, 2018 | 170 | 2018 |
| Cancer-cell-secreted CXCL11 promoted CD8+ T cells infiltration through docetaxel-induced-release of HMGB1 in NSCLC Q Gao, S Wang, X Chen, S Cheng, Z Zhang, F Li, L Huang, Y Yang, ... Journal for immunotherapy of cancer 7, 1-17, 2019 | 149 | 2019 |
| Increasing the frequency of CIK cells adoptive immunotherapy may decrease risk of death in gastric cancer patients JT Jiang, YP Shen, CP Wu, YB Zhu, WX Wei, LJ Chen, X Zheng, J Sun, ... World journal of gastroenterology: WJG 16 (48), 6155, 2010 | 147 | 2010 |
| Efficiency of CD19 chimeric antigen receptor-modified T cells for treatment of B cell malignancies in phase I clinical trials: a meta-analysis T Zhang, L Cao, J Xie, N Shi, Z Zhang, Z Luo, D Yue, Z Zhang, L Wang, ... Oncotarget 6 (32), 33961, 2015 | 135 | 2015 |
| The efficacy and safety of anti-PD-1/PD-L1 antibodies for treatment of advanced or refractory cancers: a meta-analysis T Zhang, J Xie, S Arai, L Wang, X Shi, N Shi, F Ma, S Chen, L Huang, ... Oncotarget 7 (45), 73068, 2016 | 132 | 2016 |
| Low-dose IFNγ induces tumor cell stemness in tumor microenvironment of non–small cell lung cancer M Song, Y Ping, K Zhang, L Yang, F Li, C Zhang, S Cheng, D Yue, ... Cancer research 79 (14), 3737-3748, 2019 | 120 | 2019 |
| miR-21 promotes human nucleus pulposus cell proliferation through PTEN/AKT signaling H Liu, X Huang, X Liu, S Xiao, Y Zhang, T Xiang, X Shen, G Wang, ... International journal of molecular sciences 15 (3), 4007-4018, 2014 | 113 | 2014 |
| CTL-vs Treg lymphocyte-attracting chemokines, CCL4 and CCL20, are strong reciprocal predictive markers for survival of patients with oesophageal squamous cell carcinoma JY Liu, F Li, LP Wang, XF Chen, D Wang, L Cao, Y Ping, S Zhao, B Li, ... British journal of cancer 113 (5), 747-755, 2015 | 110 | 2015 |
| Long noncoding RNA MALAT1 promotes malignant development of esophageal squamous cell carcinoma by targeting β-catenin via Ezh2 W Wang, Y Zhu, S Li, X Chen, G Jiang, Z Shen, Y Qiao, L Wang, P Zheng, ... Oncotarget 7 (18), 25668, 2016 | 109 | 2016 |
